| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| SDZ.SW - | HOLD | 0 @ CHF 60.8097 | CHF 0 | The current share valuation price of SDZ.SW based on adjusted close was CHF 60.8097. The average price that SDZ.SW shares were previous bought at was CHF 44.1701. The current market price is 37.7% higher than average price they were purchased at. The value of the holding in SDZ.SW has fallen by CHF 10,788 compared to the previous valuation of |
| IPN.PA - Ipsen SA | HOLD | 0 @ EUR 124.7 | EUR 0 | The current share valuation price of IPN.PA based on adjusted close was EUR 124.7. The average price that IPN.PA shares were previous bought at was EUR 103.683. The current market price is 20.3% higher than average price they were purchased at. The value of the holding in IPN.PA has increased by EUR 6,216 compared to the previous valuation of Ipsen SA however if the holding was sold on 2025-12-01 this would crystalise an overall loss. |
| LONN.SW - | HOLD | 0 @ CHF 595.022 | CHF 0 | The current share valuation price of LONN.SW based on adjusted close was CHF 595.022. The average price that LONN.SW shares were previous bought at was CHF 606.416. The current market price is -1.9% lower than average price they were purchased at. The value of the holding in LONN.SW has increased by CHF 143,526 compared to the previous valuation of however if the holding was sold on 2025-12-01 this would crystalise an overall loss. |
| MRK.DE - Merck KGaA | HOLD | 0 @ EUR 116.65 | EUR 0 | The current share valuation price of MRK.DE based on adjusted close was EUR 116.65. The average price that MRK.DE shares were previous bought at was EUR 115.858. The current market price is 0.7% higher than average price they were purchased at. The value of the holding in MRK.DE has increased by EUR 35,755 compared to the previous valuation of Merck KGaA however if the holding was sold on 2025-12-01 this would crystalise an overall loss. |
| NOVN.SW - | HOLD | 0 @ CHF 111.738 | CHF 0 | The current share valuation price of NOVN.SW based on adjusted close was CHF 111.738. The average price that NOVN.SW shares were previous bought at was CHF 101.338. The current market price is 10.3% higher than average price they were purchased at. The value of the holding in NOVN.SW has fallen by CHF 311,929 compared to the previous valuation of |
| NOVO-B.CO - Novo Nordisk A/S | HOLD | 0 @ DKK 42.1019 | DKK 0 | The current share valuation price of NOVO-B.CO based on adjusted close was DKK 42.1019. The average price that NOVO-B.CO shares were previous bought at was DKK 63.2354. The current market price is -33.4% lower than average price they were purchased at. The value of the holding in NOVO-B.CO has fallen by DKK 466,835 compared to the previous valuation of Novo Nordisk A/S |
| NSIS-B.CO - | HOLD | 0 @ DKK 53.7972 | DKK 0 | The current share valuation price of NSIS-B.CO based on adjusted close was DKK 53.7972. The average price that NSIS-B.CO shares were previous bought at was DKK 61.0647. The current market price is -11.9% lower than average price they were purchased at. The value of the holding in NSIS-B.CO has increased by DKK 3,906 compared to the previous valuation of however if the holding was sold on 2025-12-01 this would crystalise an overall loss. |
| ORNBV.HE - Orion Oyj | HOLD | 0 @ EUR 61.3 | EUR 0 | The current share valuation price of ORNBV.HE based on adjusted close was EUR 61.3. The average price that ORNBV.HE shares were previous bought at was EUR 60.1932. The current market price is 1.8% higher than average price they were purchased at. The value of the holding in ORNBV.HE has fallen by EUR 16,149 compared to the previous valuation of Orion Oyj |
| PHIA.AS - Koninklijke Philips NV | HOLD | 0 @ EUR 24.47 | EUR 0 | The current share valuation price of PHIA.AS based on adjusted close was EUR 24.47. The average price that PHIA.AS shares were previous bought at was EUR 21.0294. The current market price is 16.4% higher than average price they were purchased at. The value of the holding in PHIA.AS has increased by EUR 69,762 compared to the previous valuation of Koninklijke Philips NV however if the holding was sold on 2025-12-01 this would crystalise an overall loss. |
| QIA.DE - QIAGEN NV | HOLD | 0 @ EUR 40.985 | EUR 0 | The current share valuation price of QIA.DE based on adjusted close was EUR 40.985. The average price that QIA.DE shares were previous bought at was EUR 42.5094. The current market price is -3.6% lower than average price they were purchased at. The value of the holding in QIA.DE has fallen by EUR 12,960 compared to the previous valuation of QIAGEN NV |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | HOLD | 0 @ EUR 50.35 | EUR 0 | The current share valuation price of REC.MI based on adjusted close was EUR 50.35. The average price that REC.MI shares were previous bought at was EUR 53.4467. The current market price is -5.8% lower than average price they were purchased at. The value of the holding in REC.MI has fallen by EUR 25,853 compared to the previous valuation of Recordati Industria Chimica e Farmaceutica SpA |
| ROG.SW - | HOLD | 0 @ CHF 331.163 | CHF 0 | The current share valuation price of ROG.SW based on adjusted close was CHF 331.163. The average price that ROG.SW shares were previous bought at was CHF 281.464. The current market price is 17.7% higher than average price they were purchased at. The value of the holding in ROG.SW has increased by CHF 384,289 compared to the previous valuation of however if the holding was sold on 2025-12-01 this would crystalise an overall loss. |
| SAN.PA - Sanofi SA | HOLD | 0 @ EUR 86.59 | EUR 0 | The current share valuation price of SAN.PA based on adjusted close was EUR 86.59. The average price that SAN.PA shares were previous bought at was EUR 88.9526. The current market price is -2.7% lower than average price they were purchased at. The value of the holding in SAN.PA has increased by EUR 401,877 compared to the previous valuation of Sanofi SA however if the holding was sold on 2025-12-01 this would crystalise an overall loss. |
| HLN.L - Haleon PLC | HOLD | 0 @ GBP 4.26632 | GBP 0 | The current share valuation price of HLN.L based on adjusted close was GBP 4.26632. The average price that HLN.L shares were previous bought at was GBP 4.56586. The current market price is -6.6% lower than average price they were purchased at. The value of the holding in HLN.L has increased by GBP 121,278 compared to the previous valuation of Haleon PLC however if the holding was sold on 2025-12-01 this would crystalise an overall loss. |
| SECT-B.ST - | HOLD | 0 @ SEK 25.6863 | SEK 0 | The current share valuation price of SECT-B.ST based on adjusted close was SEK 25.6863. The average price that SECT-B.ST shares were previous bought at was SEK 29.0373. The current market price is -11.5% lower than average price they were purchased at. The value of the holding in SECT-B.ST has fallen by SEK 42,086 compared to the previous valuation of |
| SFZN.SW - | HOLD | 0 @ CHF 78.0216 | CHF 0 | The current share valuation price of SFZN.SW based on adjusted close was CHF 78.0216. The average price that SFZN.SW shares were previous bought at was CHF 105.102. The current market price is -25.8% lower than average price they were purchased at. The value of the holding in SFZN.SW has increased by CHF 12,716 compared to the previous valuation of however if the holding was sold on 2025-12-01 this would crystalise an overall loss. |
| SHL.DE - Siemens Healthineers AG | HOLD | 0 @ EUR 42.59 | EUR 0 | The current share valuation price of SHL.DE based on adjusted close was EUR 42.59. The average price that SHL.DE shares were previous bought at was EUR 47.9251. The current market price is -11.1% lower than average price they were purchased at. The value of the holding in SHL.DE has fallen by EUR 34,670 compared to the previous valuation of Siemens Healthineers AG |
| SN.L - Smith & Nephew PLC | HOLD | 0 @ GBP 14.1755 | GBP 0 | The current share valuation price of SN.L based on adjusted close was GBP 14.1755. The average price that SN.L shares were previous bought at was GBP 12.7572. The current market price is 11.1% higher than average price they were purchased at. The value of the holding in SN.L has fallen by GBP 54,950 compared to the previous valuation of Smith & Nephew PLC |
| SOBI.ST - | HOLD | 0 @ SEK 31.1046 | SEK 0 | The current share valuation price of SOBI.ST based on adjusted close was SEK 31.1046. The average price that SOBI.ST shares were previous bought at was SEK 26.4967. The current market price is 17.4% higher than average price they were purchased at. The value of the holding in SOBI.ST has increased by SEK 15,123 compared to the previous valuation of however if the holding was sold on 2025-12-01 this would crystalise an overall loss. |
| SOON.SW - | HOLD | 0 @ CHF 217.989 | CHF 0 | The current share valuation price of SOON.SW based on adjusted close was CHF 217.989. The average price that SOON.SW shares were previous bought at was CHF 271.632. The current market price is -19.7% lower than average price they were purchased at. The value of the holding in SOON.SW has increased by CHF 68,303 compared to the previous valuation of however if the holding was sold on 2025-12-01 this would crystalise an overall loss. |
| SRT3.DE - Sartorius AG | HOLD | 0 @ EUR 248.4 | EUR 0 | The current share valuation price of SRT3.DE based on adjusted close was EUR 248.4. The average price that SRT3.DE shares were previous bought at was EUR 215.217. The current market price is 15.4% higher than average price they were purchased at. The value of the holding in SRT3.DE has fallen by EUR 29,834 compared to the previous valuation of Sartorius AG |
| STMN.SW - | HOLD | 0 @ CHF 99.6705 | CHF 0 | The current share valuation price of STMN.SW based on adjusted close was CHF 99.6705. The average price that STMN.SW shares were previous bought at was CHF 113.693. The current market price is -12.3% lower than average price they were purchased at. The value of the holding in STMN.SW has increased by CHF 69,093 compared to the previous valuation of however if the holding was sold on 2025-12-01 this would crystalise an overall loss. |
| TECN.SW - | HOLD | 0 @ CHF 148.113 | CHF 0 | The current share valuation price of TECN.SW based on adjusted close was CHF 148.113. The average price that TECN.SW shares were previous bought at was CHF 178.532. The current market price is -17.0% lower than average price they were purchased at. The value of the holding in TECN.SW has fallen by CHF 2,221 compared to the previous valuation of |
| TUB.BR - Financiere de Tubize SA | HOLD | 0 @ EUR 212 | EUR 0 | The current share valuation price of TUB.BR based on adjusted close was EUR 212. The average price that TUB.BR shares were previous bought at was EUR 128.453. The current market price is 65.0% higher than average price they were purchased at. The value of the holding in TUB.BR has increased by EUR 18,058 compared to the previous valuation of Financiere de Tubize SA however if the holding was sold on 2025-12-01 this would crystalise an overall loss. |
| UCB.BR - UCB SA | HOLD | 0 @ EUR 239.6 | EUR 0 | The current share valuation price of UCB.BR based on adjusted close was EUR 239.6. The average price that UCB.BR shares were previous bought at was EUR 162.822. The current market price is 47.2% higher than average price they were purchased at. The value of the holding in UCB.BR has fallen by EUR 47,430 compared to the previous valuation of UCB SA |
| ZEAL.CO - | HOLD | 0 @ DKK 65.8876 | DKK 0 | The current share valuation price of ZEAL.CO based on adjusted close was DKK 65.8876. The average price that ZEAL.CO shares were previous bought at was DKK 58.9926. The current market price is 11.7% higher than average price they were purchased at. The value of the holding in ZEAL.CO has fallen by DKK 88,637 compared to the previous valuation of |
| DEMANT.CO - | HOLD | 0 @ DKK 29.322 | DKK 0 | The current share valuation price of DEMANT.CO based on adjusted close was DKK 29.322. The average price that DEMANT.CO shares were previous bought at was DKK 35.6031. The current market price is -17.6% lower than average price they were purchased at. The value of the holding in DEMANT.CO has fallen by DKK 1,028 compared to the previous valuation of |
| ALC.SW - | HOLD | 0 @ CHF 68.3118 | CHF 0 | The current share valuation price of ALC.SW based on adjusted close was CHF 68.3118. The average price that ALC.SW shares were previous bought at was CHF 77.6685. The current market price is -12.0% lower than average price they were purchased at. The value of the holding in ALC.SW has fallen by CHF 46,221 compared to the previous valuation of |
| ALK-B.CO - | HOLD | 0 @ DKK 31.2768 | DKK 0 | The current share valuation price of ALK-B.CO based on adjusted close was DKK 31.2768. The average price that ALK-B.CO shares were previous bought at was DKK 23.6007. The current market price is 32.5% higher than average price they were purchased at. The value of the holding in ALK-B.CO has increased by DKK 21,189 compared to the previous valuation of however if the holding was sold on 2025-12-01 this would crystalise an overall loss. |
| AMBU-B.CO - | HOLD | 0 @ DKK 11.5146 | DKK 0 | The current share valuation price of AMBU-B.CO based on adjusted close was DKK 11.5146. The average price that AMBU-B.CO shares were previous bought at was DKK 13.8673. The current market price is -17.0% lower than average price they were purchased at. The value of the holding in AMBU-B.CO has fallen by DKK 13,406 compared to the previous valuation of |
| AMP.MI - Amplifon SpA | HOLD | 0 @ EUR 13.33 | EUR 0 | The current share valuation price of AMP.MI based on adjusted close was EUR 13.33. The average price that AMP.MI shares were previous bought at was EUR 20.2713. The current market price is -34.2% lower than average price they were purchased at. The value of the holding in AMP.MI has increased by EUR 4,993 compared to the previous valuation of Amplifon SpA however if the holding was sold on 2025-12-01 this would crystalise an overall loss. |
| ARGX.BR - Argenx SE | HOLD | 0 @ EUR 772.2 | EUR 0 | The current share valuation price of ARGX.BR based on adjusted close was EUR 772.2. The average price that ARGX.BR shares were previous bought at was EUR 508.161. The current market price is 52.0% higher than average price they were purchased at. The value of the holding in ARGX.BR has fallen by EUR 265,394 compared to the previous valuation of Argenx SE |
| AZN.L - AstraZeneca PLC | HOLD | 0 @ GBP 157.663 | GBP 0 | The current share valuation price of AZN.L based on adjusted close was GBP 157.663. The average price that AZN.L shares were previous bought at was GBP 125.063. The current market price is 26.1% higher than average price they were purchased at. The value of the holding in AZN.L has fallen by GBP 1,238,530 compared to the previous valuation of AstraZeneca PLC |
| BAVA.CO - | HOLD | 0 @ DKK 25.0911 | DKK 0 | The current share valuation price of BAVA.CO based on adjusted close was DKK 25.0911. The average price that BAVA.CO shares were previous bought at was DKK 22.8997. The current market price is 9.6% higher than average price they were purchased at. The value of the holding in BAVA.CO has increased by DKK 11,910 compared to the previous valuation of however if the holding was sold on 2025-12-01 this would crystalise an overall loss. |
| BAYN.DE - Bayer AG | HOLD | 0 @ EUR 30.47 | EUR 0 | The current share valuation price of BAYN.DE based on adjusted close was EUR 30.47. The average price that BAYN.DE shares were previous bought at was EUR 25.4056. The current market price is 19.9% higher than average price they were purchased at. The value of the holding in BAYN.DE has fallen by EUR 6,265 compared to the previous valuation of Bayer AG |
| BIM.PA - BioMerieux | HOLD | 0 @ EUR 108.5 | EUR 0 | The current share valuation price of BIM.PA based on adjusted close was EUR 108.5. The average price that BIM.PA shares were previous bought at was EUR 119. The current market price is -8.8% lower than average price they were purchased at. The value of the holding in BIM.PA has increased by EUR 12,336 compared to the previous valuation of BioMerieux however if the holding was sold on 2025-12-01 this would crystalise an overall loss. |
| CAMX.ST - | HOLD | 0 @ SEK 55.0943 | SEK 0 | |
| COLO-B.CO - | HOLD | 0 @ DKK 78.8883 | DKK 0 | The current share valuation price of COLO-B.CO based on adjusted close was DKK 78.8883. The average price that COLO-B.CO shares were previous bought at was DKK 86.1309. The current market price is -8.4% lower than average price they were purchased at. The value of the holding in COLO-B.CO has increased by DKK 73,816 compared to the previous valuation of however if the holding was sold on 2025-12-01 this would crystalise an overall loss. |
| CTEC.L - ConvaTec Group PLC | HOLD | 0 @ GBP 2.68469 | GBP 0 | The current share valuation price of CTEC.L based on adjusted close was GBP 2.68469. The average price that CTEC.L shares were previous bought at was GBP 3.26342. The current market price is -17.7% lower than average price they were purchased at. The value of the holding in CTEC.L has fallen by GBP 3,636 compared to the previous valuation of ConvaTec Group PLC |
| ABVX.PA - Abivax SA | HOLD | 0 @ EUR 106.2 | EUR 0 | |
| DIA.MI - DiaSorin SpA | HOLD | 0 @ EUR 61.32 | EUR 0 | The current share valuation price of DIA.MI based on adjusted close was EUR 61.32. The average price that DIA.MI shares were previous bought at was EUR 95.1491. The current market price is -35.6% lower than average price they were purchased at. The value of the holding in DIA.MI has fallen by EUR 5,078 compared to the previous valuation of DiaSorin SpA |
| DIM.PA - Sartorius Stedim Biotech | HOLD | 0 @ EUR 208.1 | EUR 0 | The current share valuation price of DIM.PA based on adjusted close was EUR 208.1. The average price that DIM.PA shares were previous bought at was EUR 198.449. The current market price is 4.9% higher than average price they were purchased at. The value of the holding in DIM.PA has increased by EUR 9,391 compared to the previous valuation of Sartorius Stedim Biotech however if the holding was sold on 2025-12-01 this would crystalise an overall loss. |
| EL.PA - EssilorLuxottica SA | HOLD | 0 @ EUR 307 | EUR 0 | The current share valuation price of EL.PA based on adjusted close was EUR 307. The average price that EL.PA shares were previous bought at was EUR 248.629. The current market price is 23.5% higher than average price they were purchased at. The value of the holding in EL.PA has fallen by EUR 226,187 compared to the previous valuation of EssilorLuxottica SA |
| ERF.PA - Eurofins Scientific SE | HOLD | 0 @ EUR 58.96 | EUR 0 | The current share valuation price of ERF.PA based on adjusted close was EUR 58.96. The average price that ERF.PA shares were previous bought at was EUR 57.9209. The current market price is 1.8% higher than average price they were purchased at. The value of the holding in ERF.PA has increased by EUR 16,113 compared to the previous valuation of Eurofins Scientific SE however if the holding was sold on 2025-12-01 this would crystalise an overall loss. |
| FME.DE - Fresenius Medical Care AG | HOLD | 0 @ EUR 40.71 | EUR 0 | The current share valuation price of FME.DE based on adjusted close was EUR 40.71. The average price that FME.DE shares were previous bought at was EUR 47.8642. The current market price is -14.9% lower than average price they were purchased at. The value of the holding in FME.DE has fallen by EUR 48,200 compared to the previous valuation of Fresenius Medical Care AG |
| FRE.DE - Fresenius SE & Co KGaA | HOLD | 0 @ EUR 46.37 | EUR 0 | The current share valuation price of FRE.DE based on adjusted close was EUR 46.37. The average price that FRE.DE shares were previous bought at was EUR 42.5137. The current market price is 9.1% higher than average price they were purchased at. The value of the holding in FRE.DE has fallen by EUR 168,139 compared to the previous valuation of Fresenius SE & Co KGaA |
| GALD.SW - | HOLD | 0 @ CHF 169.44 | CHF 0 | The current share valuation price of GALD.SW based on adjusted close was CHF 169.44. The average price that GALD.SW shares were previous bought at was CHF 119.169. The current market price is 42.2% higher than average price they were purchased at. The value of the holding in GALD.SW has fallen by CHF 130,101 compared to the previous valuation of |
| GETI-B.ST - | HOLD | 0 @ SEK 19.7026 | SEK 0 | The current share valuation price of GETI-B.ST based on adjusted close was SEK 19.7026. The average price that GETI-B.ST shares were previous bought at was SEK 17.2685. The current market price is 14.1% higher than average price they were purchased at. The value of the holding in GETI-B.ST has increased by SEK 6,437 compared to the previous valuation of however if the holding was sold on 2025-12-01 this would crystalise an overall loss. |
| GMAB.CO - | HOLD | 0 @ DKK 273.538 | DKK 0 | The current share valuation price of GMAB.CO based on adjusted close was DKK 273.538. The average price that GMAB.CO shares were previous bought at was DKK 186.369. The current market price is 46.8% higher than average price they were purchased at. The value of the holding in GMAB.CO has increased by DKK 14,560 compared to the previous valuation of however if the holding was sold on 2025-12-01 this would crystalise an overall loss. |
| GRF.MC - Grifols SA | HOLD | 0 @ EUR 10.505 | EUR 0 | The current share valuation price of GRF.MC based on adjusted close was EUR 10.505. The average price that GRF.MC shares were previous bought at was EUR 10.3964. The current market price is 1.0% higher than average price they were purchased at. The value of the holding in GRF.MC has fallen by EUR 3,131 compared to the previous valuation of Grifols SA |
| GSK.L - GlaxoSmithKline PLC | HOLD | 0 @ GBP 20.5112 | GBP 0 | The current share valuation price of GSK.L based on adjusted close was GBP 20.5112. The average price that GSK.L shares were previous bought at was GBP 16.9988. The current market price is 20.7% higher than average price they were purchased at. The value of the holding in GSK.L has increased by GBP 109,650 compared to the previous valuation of GlaxoSmithKline PLC however if the holding was sold on 2025-12-01 this would crystalise an overall loss. |
| HIK.L - | HOLD | 0 @ GBP 17.9473 | GBP 0 | The current share valuation price of HIK.L based on adjusted close was GBP 17.9473. The average price that HIK.L shares were previous bought at was GBP 23.9671. The current market price is -25.1% lower than average price they were purchased at. The value of the holding in HIK.L has increased by GBP 14,140 compared to the previous valuation of however if the holding was sold on 2025-12-01 this would crystalise an overall loss. |